MS-linked genetic change tied to smaller brains under 55
Key Takeaway
A genetic change linked to MS was tied to smaller brain volume in middle-aged people without MS, but not in older people.
What They Found
Researchers studied brain scans from people without MS. They looked for a genetic change already linked to more severe MS and loss of brain tissue in people with MS. Among people under 55, those with the change had lower total brain volume. They also had less gray matter, a type of brain tissue. The researchers did not find these links in older participants.
Who Should Care and Why
The study included people aged 45 or older who did not have MS. It examined a genetic change already linked to brain tissue loss in people with MS. The finding suggests that this link may extend beyond MS. The link appeared in middle-aged participants, but not older participants. The study did not test whether the genetic change affects brain volume in people with MS.
Important Considerations
Researchers analyzed 10,308 brain scans from 4,815 people without MS. They compared brain volume across people and examined scans taken over time. The study found a link, but it does not show that the genetic change caused brain tissue loss.
AI-generated summary — for informational purposes only, not medical advice
Categories:
You May Also Like
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More
11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More
11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More
11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More
10/9/2026
A mouse study suggests prepared red blood cells may calm MS-like immune attacks. Learn why liver cel
Read More
10/9/2026
See how lab-grown nerve cells move a key protein, why this may matter for nerve health, and why the
Read MoreUnderstanding MS Research
Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.